Effect of Mirtazapine Treatment on Serum Levels of Brain-Derived Neurotrophic Factor and Tumor Necrosis Factor-α in Patients of Major Depressive Disorder with Severe Depression
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: This study evaluated the clinical efficacy of mirtazapine and its effect on serum brain-derived neurotrophic factor (BDNF) and tumor necrosis factor-α (TNF-α) levels in patients of major-depressive disorder (MDD) with severe depression. METHODS: Patients (aged 18-60) with MDD diagnosed by DSM-IV criteria, and Hamilton Rating Scale for Depression (HAM-D) score ≥25 were included (n = 30). Mirtazapine was given in the doses of 30 mg/day. All patients were followed up for 12 weeks for the evaluation of clinical efficacy, safety along with serum BDNF and TNF-α levels. RESULTS: HAM-D score at the start of treatment was 30.1 ± 1.92, which significantly (p < 0.05) reduced to 13.47 ± 1.77 at 12 weeks of treatment. In responders, mean serum BDNF levels at the start of treatment were 2.32 ± 0.3 ng/ml, which significantly (p < 0.05) increased to 2.79 ± 0.33 ng/ml at 12 weeks of treatment and mean serum TNF-α levels at the start were 5.18 ± 0.67 pg/ml, which significantly decreased to 4.36 ± 0.72 pg/ml (p < 0.05) at 12 weeks of treatment. CONCLUSION: Our results suggest that mirtazapine is effective and well tolerated in severely depressed patients and treatment response is associated with an increase in serum BDNF and a decrease in serum TNF-α levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, however, Gupta et al. (203) found that successful treatment with mirtazapine led to a decrease in serum TNF-α levels.”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [203]
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
Brunoni, A. R., Lopes, M., & Fregni, F. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009309 · Cited by 972
Hannestad, J., DellaGioia, N., & Bloch, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.132 · Cited by 914
A Review of the Pharmacological and Clinical Profile of Mirtazapine
Anttila, S. A. K., & Leinonen, E. V. J. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00198.x · Cited by 795
Critical Role of Brain-Derived Neurotrophic Factor in Mood Disorders
Hashimoto, K., Shimizu, E., & Iyo, M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.02.003 · Cited by 522
Tuglu, C., Kara, S. H., Caliyurt, O., Vardar, E., & Abay, E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1566-z · Cited by 391
Effect of treatment on serum brain–derived neurotrophic factor levels in depressed patients
Gonul, A. S., Akdeniz, F., Taneli, F., Donat, O., Eker, Ç., & Vahip, S. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0578-6 · Cited by 375
Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects
Hoshaw, B. A., Malberg, J. E., & Lucki, I. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.007 · Cited by 348
Altar, C. A., Whitehead, R. E., Chen, R., Wörtwein, G., & Madsen, T. M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00073-8 · Cited by 300
Dias, B. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00198-9 · Cited by 274
A psychoneuroimmunological review on cytokines involved in antidepressant treatment response
Janssen, D. G. A., Caniato, R. N., Verster, J. C., & Baune, B. T. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1103 · Cited by 240
Gervasoni, N., Aubry, J.-M., Bondolfi, G., Osiek, C., Schwald, M., Bertschy, G., & Karege, F. (2005) · Neuropsychobiology · doi:10.1159/000085725 · Cited by 203
Serum BDNF levels before treatment predict SSRI response in depression
Wolkowitz, O. M., Wolf, J., Shelly, W., Rosser, R., Burke, H. M., Lerner, G. K., Reus, V. I., Nelson, J. C., Epel, E. S., & Mellon, S. H. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.06.013 · Cited by 174
Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat
Zhang, Y., Gu, F., Chen, J., & Dong, W. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.095 · Cited by 135
Başterzi, A. D., Yazıcı, K. U., Aslan, E., Delıalıoğlu, N., Taşdelen, B., Acar, Ş. T., & Yazıcı, A. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.016 · Cited by 96
Comparison of the Effects of Mirtazapine and Fluoxetine in Severely Depressed Patients
Versiani, M., Moreno, R. A., van Moorsel, C. J. A., Schutte, A. J., & Study, C. E. O. A. (2005) · CNS Drugs · doi:10.2165/00023210-200519020-00004 · Cited by 87
Management of depression in adults
Timonen, M., & Liukkonen, T. (2008) · BMJ · doi:10.1136/bmj.39478.609097.be · Cited by 80
Rogóż, Z., Skuza, G., & Legutko, B. (2005) · PubMed · Cited by 72
Deuschle, M., Gilles, M., Scharnholz, B., Lederbogen, F., Lang, U., & Hellweg, R. (2012) · Pharmacopsychiatry · doi:10.1055/s-0032-1321908 · Cited by 60
Engel, D. F., Zomkowski, A. D. E., Lieberknecht, V., Rodrigues, A. L. S., & Gabilan, N. H. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.02.013 · Cited by 60
Kang, R., Chang, H., Wong, M., Choi, M., Park, J., Lee, H., Jung, I., Joe, S., Kim, L., Kim, S., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109105457 · Cited by 55
Schulte‐Herbrüggen, O., Fuchs, E., Abumaria, N., Ziegler, A., Danker‐Hopfe, H., Hiemke, C., & Hellweg, R. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22080 · Cited by 51
Cooke, J. D., Grover, L. M., & Spangler, P. R. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.037 · Cited by 47
The influence of mianserin on TNF-α, IL-6 and IL-10 serum levels in rats under chronic mild stress
Manikowska, K., Mikołajczyk, M., Mikołajczak, P. Ł., & Bobkiewicz-Kozłowska, T. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.06.003 · Cited by 39
Katsuki, A., Yoshimura, R., Hori, H., Umene‐Nakano, W., Ikenouchi, A., Hayashi, K., Atake, K., & Nakamura, J. (2013) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(13)70635-7 · Cited by 2
Cited by
Liu, J. J., Wei, Y. B., Strawbridge, R., Bao, Y., Chang, S., Shi, L., Que, J., Gadad, B. S., Trivedi, M. H., Kelsoe, J. R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0474-5 · Cited by 429
Cytokine Research in Depression: Principles, Challenges, and Open Questions
Himmerich, H., Patsalos, O., Lichtblau, N., Ibrahim, M. A. A., & Dalton, B. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00030 · Cited by 313
Haroon, E., Daguanno, A. W., Woolwine, B. J., Goldsmith, D. R., Baer, W. M., Wommack, E. C., Felger, J. C., & Miller, A. H. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.026 · Cited by 291
“TNF has been one of the most measured markers of inflammation in this literature, with multiple studies showing elevations in TNF in non-responders following treatment compared to treatment responders (Eller et al., 2008; Gupta et al., 2016; Lanquillon et al., 2000; Strawbridge et al., 2015).”
ResultEffect of antidepressant treatment on peripheral inflammation markers – A meta-analysis
Więdłocha, M., Marcinowicz, P., Krupa, R., Janoska-Jaździk, M., Janus, M., Dębowska, W., Mosiołek, A., Waszkiewicz, N., & Szulc, A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.026 · Cited by 233
“Animal studies followed by clinical trials confirmed that antidepressant drugs act not only on the neurotransmission but also result in increases of BNDF levels (Gupta et al., 2016).”
BackgroundArteaga-Henríquez, G., Simon, M. S., Burger, B., Weidinger, E., Wijkhuijs, A., Arolt, V., Birkenhager, T. K., Musil, R., Müller, N., & Drexhage, H. A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00458 · Cited by 215
“, 2016 (51) Mirtazapine (NaSSA) TNFα Higher response rates compared”
Background
Metadata
- Authors
- Gupta, R., Gupta, K., Tripathi, A. K., Bhatia, M. S., & Gupta, L. K.
- Affiliations
- University College of Medical Sciences (IN)
- Lady Hardinge Medical College (IN)
- Venue
- Pharmacology
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 97
- Issue
- 3-4
- Pages
- 184-188
- ISSN
- 0031-7012 (ISSN-L)
- 1423-0313
- OpenAlex
- W2265991184
- Cited by
- 61
- References
- 28
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 1 · 2023: 8 · 2022: 4 · 2021: 11 · 2020: 3 · 2019: 7 · 2018: 8 · 2017: 4 · 2016: 2
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- mirtazapine, major depressive disorder, severe depression, brain-derived neurotrophic factor, TNF-α, serum biomarkers, antidepressant efficacy, treatment response, drug safety
- MeSH terms
- Mirtazapine, Adolescent, Adult, Antidepressive Agents, Tricyclic, Depression, Major Depressive Disorder, Depressive Disorder, Major, Female, Humans, Male, Mianserin, Middle Aged, Tumor Necrosis Factor-alpha, Treatment Outcome, Brain-Derived Neurotrophic Factor, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.